Follicular Phase

• 

  Subject Areas on Research

  • A double-blind randomized study on the effects of red clover isoflavones on the endometrium. 
  • A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles. 
  • Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil beta2-adrenergic receptors: Gs protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity. 
  • Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity. 
  • Aging and dietary modulation of elastase and interleukin-1 beta secretion. 
  • Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition. 
  • Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls. 
  • Combined impact of the number of pre-ovulatory oocytes and cryopreservation on IVF outcome. 
  • Early follicular rise of serum progesterone concentration in response to a flare-up effect of gonadotrophin-releasing hormone agonist impairs follicular recruitment for in-vitro fertilization. 
  • Effects of intranasal administration of norethisterone on folliculogenesis, cervical mucus, vaginal cytology, endometrial morphology and reproductive-endocrine profile in women. 
  • Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system. 
  • Estrogen regulation of adipose tissue lipoprotein lipase--possible mechanism of body fat distribution. 
  • Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment. 
  • Hyperandrogenemia in human immunodeficiency virus-infected women with the lipodystrophy syndrome. 
  • Implantation and pregnancy rates in relation to oestradiol and progesterone profiles in cycles with and without the use of gonadotrophin-releasing hormone agonist suppression. 
  • Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder. 
  • Menstrual cycle effects on caffeine elimination in the human female. 
  • Monitoring gonadotropin-stimulated cycles for in vitro fertilization and embryo transfer. 
  • On the frequency of intercourse around ovulation: evidence for biological influences. 
  • PTSD in women is associated with a block in conversion of progesterone to the GABAergic neurosteroids allopregnanolone and pregnanolone measured in plasma. 
  • Plasma concentrations of 11-deoxycorticosterone in women during the menstrual cycle. 
  • Prepulse inhibition deficits in women with PTSD. 
  • Steroidogenesis in porcine atretic follicles: loss of aromatase activity in isolated granulosa and theca. 
  • Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotropin values in an in vitro fertilization program. 
  • The movement of human spermatozoa in cervical mucus. 
  • The relation of free plasma tryptophan to anger, hostility, and aggression in a nonpatient sample of adult men and women. 
  • Use of gonadotrophin-releasing hormone agonists in controlled ovarian hyperstimulation for in vitro fertilization. 
  • Utility of fluoroimmunoassay in detecting luteinizing hormone surges in spontaneous and human menopausal gonadotropin-stimulated menstrual cycles.